{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:51:04Z","timestamp":1791219064322,"version":"4.1.0"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R44AI125017-01"],"award-info":[{"award-number":["1R44AI125017-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>\n                    Coccidioidomycosis is a systemic fungal infection caused by the inhalation of the arthroconidia of either of two closely related dimorphic fungi,\n                    <jats:named-content content-type=\"genus-species\">Coccidioides immitis<\/jats:named-content>\n                    and\n                    <jats:named-content content-type=\"genus-species\">C. posadasii<\/jats:named-content>\n                    , that are endemic in the southwestern United States and other areas in the Western Hemisphere. Chronic cavitary pulmonary infections and extrapulmonary sites of infection are very difficult to treat and often require lifelong azole therapy.\n                  <\/jats:p>","DOI":"10.1128\/aac.01715-18","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T08:50:45Z","timestamp":1542271845000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":61,"title":["APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental\n                    <i>Coccidioides immitis<\/i>\n                    Pneumonia"],"prefix":"10.1128","volume":"63","author":[{"given":"Suganya","family":"Viriyakosol","sequence":"first","affiliation":[{"name":"VA Healthcare, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mili","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Amplyx Pharmaceuticals, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, UC San Diego School of Medicine, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Covel","sequence":"additional","affiliation":[{"name":"Amplyx Pharmaceuticals, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinlyn A.","family":"Soltow","sequence":"additional","affiliation":[{"name":"Amplyx Pharmaceuticals, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trzoss","sequence":"additional","affiliation":[{"name":"Amplyx Pharmaceuticals, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Joy","family":"Shaw","sequence":"additional","affiliation":[{"name":"Amplyx Pharmaceuticals, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Fierer","sequence":"additional","affiliation":[{"name":"VA Healthcare, San Diego, California, USA"},{"name":"Amplyx Pharmaceuticals, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020002"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/15572536.2003.11833250"},{"key":"e_1_3_2_4_2","article-title":"The endozoan, small-mammal reservoir hypothesis and the life cycle of Coccidioides species","author":"Taylor JW","unstructured":"Taylor JW, Barker BM. The endozoan, small-mammal reservoir hypothesis and the life cycle of Coccidioides species. Med Mycol, in press.","journal-title":"Med Mycol"},{"key":"e_1_3_2_5_2","first-page":"1","article-title":"Increase in reported coccidioidomycosis: United States, 1998\u20132011","volume":"62","author":"Tsang CA","year":"2013","unstructured":"Tsang CA, Tabnak F, Vugia DJ, Benedict K, Chiller T, Park BJ. 2013. Increase in reported coccidioidomycosis: United States, 1998\u20132011. MMWR Morb Mortal Wkly Rep 62:1\u201320.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0203.960305"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1406.019"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw360"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80371-4"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02634-16"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00366-11"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03481.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M301044200"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/cb300235m"},{"key":"e_1_3_2_15_2","unstructured":"Matsukura M. August 2013. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same. US patent US 8513287 B2."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm980539w"},{"key":"e_1_3_2_17_2","volume-title":"Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"Hata K","year":"2011","unstructured":"Hata K, Horii T, Miyazaki M, Watanabe NA. 2011. In vitro and in vivo antifungal activities of E1211, a water-soluble prodrug of E1210, abstr F1-1377. Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00523-18"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02542-17"},{"key":"e_1_3_2_20_2","volume-title":"Phase 1 study to assess safety, tolerability and pharmacokinetics of single and multiple oral doses of APX001 and to investigate the effect of food on APX001 bioavailability, CA poster 1860","author":"Hodges MR","year":"2017","unstructured":"Hodges MR, Ople E, Shaw KJ, Mansbach RS, van Marle S, van Hoogdalem E, Kramer W, Wedel P. 2017. Phase 1 study to assess safety, tolerability and pharmacokinetics of single and multiple oral doses of APX001 and to investigate the effect of food on APX001 bioavailability, CA poster 1860. IDweek 2017, San Diego, CA."},{"key":"e_1_3_2_21_2","volume-title":"First-in-human study to assess safety, tolerability and pharmacokinetics of APX001 administered by intravenous infusion to healthy subjects, CA poster 1840","author":"Hodges MR","year":"2017","unstructured":"Hodges MR, Ople E, Shaw KJ, Mansbach RS, van Marle S, van Hoogdalem E, Wedel P, Kramer W. 2017. First-in-human study to assess safety, tolerability and pharmacokinetics of APX001 administered by intravenous infusion to healthy subjects, CA poster 1840. IDweek 2017, San Diego, CA."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.000349"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00425-18"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05414-11"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00570-11"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.327-330.2001"},{"key":"e_1_3_2_27_2","volume-title":"CLSI document M27-A3","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.40.3.912-916.1983"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004762"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.1.13"},{"key":"e_1_3_2_31_2","volume-title":"abstr F1-843","author":"Horii T","year":"2010","unstructured":"Horii T, Okubo M, Miyazaki M, Hata K, Watanabe NA. 2010. In vivo pharmacodynamic correlates of success for E1210 treatment of disseminated candidiasis, abstr F1-843. Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA."},{"key":"e_1_3_2_32_2","volume-title":"CLSI document M38-A2","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03944-14"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02319-17"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.1209"},{"key":"e_1_3_2_36_2","volume-title":"abstr. O0943","author":"Petraitis V","year":"2018","unstructured":"Petraitis V, Petraitiene R, Maung BBW, Mansbach RS, Shaw KJ, Walsh TJ. 2018. Efficacy of APX001 in treatment of Candida endophthalmitis and hematogenous meningoencephalitis in the non-neutropenic rabbit model, abstr. O0943. European Congress of Clinical Microbiology and Infectious Diseases, Madrid, Spain."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir642"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-13-121"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00597-12"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.6.1132"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01715-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01715-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:36:17Z","timestamp":1645461377000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01715-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1128\/AAC.01715-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.01715-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"2018-08-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01715-18"}}